Page 12 - Vaccine

Centre, states working jointly to stop spread of Lumpy Skin Disease: PM

Says indigenous vaccine and movement of animals being stopped to control the spread of LSD

Top Headlines: Gyanvapi verdict today, Russia's discounted oil, and more

In a bid to counter the growing clamour among the G7 nations to enforce a price cap on Russian oil, Moscow told New Delhi it is willing to provide petroleum at even lower rates than before to India

Bharat Biotech awaits booster dose nod for intranasal vaccine iNCOVACC

Bharat Biotech did not comment on its plans to make this vaccine available for young children

Fight against Covid-19: Here is a list of vaccines approved in India

Besides Bharat Biotech's nasal vaccine, India has 13 vaccines to fight against Covid-19. Two have been approved for manufacturing, while 11 have been approved for emergency use

National Immunisation Mission: How indigenous vaccines can go a long way

The locally developed Ceravac can play a critical role in the efficacy of the National Immunisation Mission

US holds 80% of global vaccine supply with 35% of monkeypox cases: Report

The analysis compared vaccine access and monkeypox cases in more than a dozen countries.

India-made cervical cancer vaccine Ceravac to cost Rs 200-400 per dose

Serum India's product made in collaboration with state-run biotechnology department, expected to bring down prices

SEC recommends Biological E's vaccine against S pneumonia for infants

Biological E Limited on Thursday announced that the Subject Expert Committee of Central Drugs Standard Control Organisation (CDSCO) reviewed and approved the Phase 3 infants' clinical trial data and recommended for manufacture its 14-valent paediatric vaccine (investigational pneumococcal polysaccharide conjugate vaccine PCV14) against S pneumonia infection, in single-dose and multi-dose presentations. A press release from the city-based vaccine maker said the PCV14 can be administered to infants at six, 10 and 14 weeks of age. Streptococcus pneumoniae infection continues to be a leading cause of child mortality under 5 years of age in India and in developing countries. With the PCV14 vaccine, BE hopes to contribute to the prevention of invasive pneumococcal disease and protect millions of lives globally. The safety analysis of the vaccine revealed that all the adverse events were mild to moderate in their intensity and with no grade-3 & 4 events reported. Mahima Datla, Managing ..

South Africa's Aspen, India's Serum Institute sign vaccines deal for Africa

South Africa's Aspen Pharmacare has signed a deal with the Serum Institute of India to manufacture and sell four Aspen-branded vaccines for Africa

Covishield usage highest as precaution dose for Covid, says report

The usage of Covishield has been the highest as the precaution dose for COVID-19 as compared to other vaccines, said Union Health Ministry sources

Monkeypox shots not getting to people who need them the most: US data

The Biden administration said Friday there's enough monkeypox vaccine available now but health officials say the shots aren't getting to some of the people who need the protection the most. About 10% of monkeypox vaccine doses have been given to Black people, even though they account for one-third of US cases, according to the Centres for Disease Control and Prevention. The new numbers come from 17 states and two cities, and represent the most comprehensive details yet on who has been getting the two-dose vaccines. Similar disparities had been reported previously by a few states and cities. Most US monkeypox cases have been in men who have sex with men, but officials have stressed that anyone can catch the virus. Experts offered several possible explanations for the disparity. It may be related to how and where shots are being offered and publicised. It may be that some Black men don't trust doctors and government public health efforts. Or they may be less willing to identify ...

Number of newly reported monkeypox cases decreases worldwide: WHO

Worldwide, 5,907 cases were reported during the week, compared to 7,477 the week before

UK trying out smaller monkeypox vaccine doses amid shortage: Report

Three National Health Service (NHS) sites -- one in Manchester and two in London -- will start administering doses that are five times smaller than the original dose, at 0.1 ml instead of 0.5 ml.

Experts question reliance on monkeypox vax with little data, short supply

The Bavarian Nordic shot has not undergone clinical trials to evaluate the vaccine's ability to prevent monkeypox in humans, though initial studies suggest it will provide some protection

EU regulator approves plan to increase monkeypox vaccine supplies

A smaller dose of the monkeypox vaccine appears to still be effective and can be used to stretch the current supply by five times, the European Medicines Agency said Friday, echoing a recommendation made earlier this month by the US Food and Drug Administration. The EU drug regulator said in a statement that injecting people with just one fifth the regular dose of the smallpox vaccine made by Bavarian Nordic appeared to produce similar levels of antibodies against monkeypox as a full dose. The approach calls for administering Bavarian Nordic's vaccine with an injection just under the skin rather than into deeper tissue, a practice that may stimulate a better immune response. People still need to get two doses, about four weeks apart. The EMA said national authorities could decide, as a temporary measure to use smaller doses of the vaccine to protect vulnerable people during the ongoing monkeypox outbreak. EU health commissioner Stella Kyriakides said the decision would allow the ..

India supplies nearly 60% of vaccines used worldwide: FM Sitharaman

Finance Minister Nirmala Sitharaman on Wednesday said nearly 60 per cent of all the vaccines used in the world are produced in India and over the decades, the country has made remarkable contribution to vaccinating the world. India today is double dosing every citizen and produced COVID-19 vaccines even during the lockdown period, she added. Launching the book 'India's Vaccine Growth Story' by Sajjan Singh Yadav, Additional Secretary, Expenditure Department, Sitharaman said it is in the country's DNA to be able to contribute to world vaccination. "Over the decades India has made remarkable contribution. Nearly 60 per cent of all the vaccines which are used in the world are produced in India. India has singular contribution to make to the world in terms of vaccination and that which is being produced and supplied to the entire world," Sitharaman said. Today, the country is double dosing every citizen, she said, adding it is not easy to produce and execute COVID vaccination at that .

Drones in healthcare: Delivering vaccines to life-saving drugs sustainably

State governments, as well as e-commerce players, are taking initiatives to launch healthcare services through drones into remote areas

At least 8 Indian companies working to develop monkeypox vaccine: Report

Among the companies that are working with ICMR are Serum Institute of India (SII), Reliance Life Sciences, Dr Reddy's Laboratories, and Biological E

Smallpox vax protection against monkeypox may not be lasting: Lancet study

Although the smallpox jab has shown to reduce the chance of symptomatic infection and severe illness from monkeypox, protection may decline over time.

Polio vax boosters offered to children in London: Here's what experts say

In June, the UK Health Security Agency reported that polio virus had been detected in sewage in north and east London post which vaccine boosters were offered.